Methylating agents: their target amino acids in nuclear proteins

Area of Science:

• Chemical carcinogenesis
• Molecular toxicology
• Chromatin biochemistry

Background:

• Methylating agents are known carcinogens.
• Understanding their interaction with nuclear components is crucial for elucidating mechanisms of carcinogenesis.
• Specific target sites in chromatin may correlate with carcinogenic potency.

Purpose of the Study:

• To investigate the correlation between carcinogenic potency of methylating compounds and their nuclear protein targets.
• To compare the nuclear metabolism of weak and potent methylating carcinogens.

Main Methods:

• Radioactive labeling of four methylating compounds: dimethyl sulphate (DMS), methyl methanesulphonate (MMS), N-methyl-N-nitrosourea (MNU), and N-methyl-N'-nitro-N-nitrosoguanosine (MNNG).
• Incubation with cultured primary hepatocytes and V79 Chinese hamster cell line.
• Analysis of methylated amino acids in purified histones (H1, H3) and non-histone nuclear proteins (HMG1, HMG2).

Main Results:

• Weak carcinogens (DMS, MMS) methylated cysteine and histidine in histones (H1, H3) and non-histone proteins (HMG1, HMG2).
• Potent carcinogens (MNU, MNNG) predominantly methylated lysine and arginine residues in nuclear proteins.
• Trace amounts of methylated cysteine and histidine were observed with potent carcinogens, and methylated lysine/arginine with weaker ones.

Conclusions:

• Preliminary data suggest distinct amino acid methylation patterns in nuclear proteins by methylating carcinogens of differing potencies.
• These findings indicate specific nuclear protein targets that may contribute to differential carcinogenic effects.
• The observed patterns are analogous to specific DNA base methylation by these agents.